(Sialyl)Lewis Antigen (sialyl)lewis ( (S (Si (Sia BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 () 2 6 0 0 1 1 1
Glycosphingolipids, N-, glycosphingolipids, G Gl Gly Glyc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 ,-,- 4 10 0 0 0 0 1
Cancer Cell cancer C Ca Can Canc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 - 1 8 0 0 0 0 1
Differentiation Program differentiation D Di Dif Diff BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 4 0 0 0 0 1
Authors Authors authors A Au Aut Auth BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 1 no 0 10 1 0 0 0 1
Di Wang, di D Di Di Di BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 0 1 ,,.,..-, 8 10 1 0 0 0 1
Manfred Wuhrer manfred M Ma Man Manf BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 0 1 no 0 1 1 0 0 0 1
Correspondence Correspondence correspondence C Co Cor Corr BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 2 no 0 7 1 0 0 0 1
Graphical Abstract graphical G Gr Gra Grap BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 2 no 0 10 1 0 0 0 1
m.wuhrer@lumc.nl m.wuhrer@lumc.nl m.wuhrer@lumc.nl m m. m.w m.wu BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 1 0 0 2 .@. 3 10 1 0 0 0 1
In Brief in I In In In BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 0 3 no 0 10 1 0 0 0 1
An integrated an A An An An BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 0 3 no 0 7 0 0 0 0 1
glycosylation features glycosylation g gl gly glyc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 3 no 0 9 0 0 0 0 1
(sialyl)Lewis structure (sialyl)lewis ( (s (si (sia BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 3 () 2 9 0 0 0 0 1
group antigens group g gr gro grou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 no 0 8 0 0 0 0 1
across N-, across a ac acr acro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 -,-, 4 7 0 0 0 0 1
glycosphingolipid glycans. glycosphingolipid g gl gly glyc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 3 . 1 7 0 0 0 0 1
Colon-like lines colon-like C Co Col Colo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 3 - 1 7 0 0 0 0 1
abundant (sialyl)Lewis abundant a ab abu abun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 (), 3 9 0 0 0 0 1
while undifferentiated while w wh whi whil BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 no 0 8 0 0 0 0 1
expressed H expressed e ex exp expr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 no 0 6 0 0 0 0 1
antigens and antigens a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 3 -/. 3 9 0 0 0 0 1
The observed the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 3 no 0 7 0 0 0 0 1
across glycan across a ac acr acro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 no 0 9 0 0 0 0 1
correlations with correlations c co cor corr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 no 0 5 0 0 0 0 1
glycosyltransferases and glycosyltransferases g gl gly glyc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 3 no 0 7 0 0 0 0 1
transcription factors transcription t tr tra tran BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 no 0 10 0 0 0 0 1
certain transcription certain c ce cer cert BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 no 0 10 0 0 0 0 1
CDX1 contribute cdx1 C CD CDX CDX1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 3 no 0 6 0 0 0 0 1
upregulation of upregulation u up upr upre BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 3 () 2 8 0 0 0 0 1
antigens on antigens a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 3 no 0 8 0 0 0 0 1
classes via classes c cl cla clas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 no 0 7 0 0 0 0 1
glycosyltransferases FUT3/4. glycosyltransferases g gl gly glyc BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 3 /. 2 8 0 0 0 0 1
2024, Mol 2024, 2 20 202 2024 BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 0 8 ,(), 4 3 0 1 0 0 1
© 2024 © © © © © BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 0 8 . 1 9 0 1 0 0 1
Molecular Biology. molecular M Mo Mol Mole BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 8 .(://./ 7 10 0 1 0 0 1
licenses/by/4.0/). licenses/by/4.0/). licenses/by/4.0/). l li lic lice BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 8 //./). 6 1 0 1 0 0 1
https://doi.org/10.1016/j.mcpro.2024.100776 https://doi.org/10.1016/j.mcpro.2024.100776 https://doi.org/10.1016/j.mcpro.2024.100776 h ht htt http BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 0 8 ://././... 10 4 0 1 0 0 1
RESEARCH RESEARCH research R RE RES RESE BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 1 1 0 0 0 0 0 0 11 no 0 10 0 1 0 0 0
Highlights Highlights highlights H Hi Hig High BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 10 0 1 0 0 1
• Glycosylation • • • • • BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 0 0 •. 2 8 0 1 0 0 1
• For • • • • • BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 0 0 •() 3 10 0 1 0 0 1
glycan classes. glycan g gl gly glyc BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 5 . 1 10 0 1 0 0 1
• Colon-like • • • • • BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 0 6 •-(). 5 8 0 0 0 0 1
• High • • • • • BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 0 6 •(). 4 10 0 0 0 0 1
RESEARCH RESEARCH research R RE RES RESE BLOCKSTART PAGEEND NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 1 1 0 0 0 0 0 0 11 no 0 10 0 1 0 0 0
(Sialyl)Lewis Antigen (sialyl)lewis ( (S (Si (Sia BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 () 2 8 1 0 1 0 1
Glycosphingolipids, N-, glycosphingolipids, G Gl Gly Glyc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 ,-,- 4 9 1 0 0 0 1
Colorectal Cancer colorectal C Co Col Colo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 no 0 10 1 0 0 0 1
Colon-Like Differentiation colon-like C Co Col Colo BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 - 1 7 1 0 0 0 1
Di Wang di D Di Di Di BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 0 0 ,,,., 5 8 1 0 0 0 1
Guinevere S. guinevere G Gu Gui Guin BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 0 0 ..-,,,* 7 10 1 0 0 0 1
Alterations in alterations A Al Alt Alte BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 - 1 9 1 0 0 0 1
cer, including cer, c ce cer cer, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 ,().,- 6 9 1 0 0 0 1
sylation of sylation s sy syl syla BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 no 0 9 1 0 0 0 1
studied for studied s st stu stud BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 , 1 9 1 0 0 0 1
overview of overview o ov ove over BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 9 1 0 0 0 1
of different of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ., 2 9 1 0 0 0 1
we compared we w we we we BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 -,-, 4 9 1 0 0 0 1
glycosphingolipid glycans glycosphingolipid g gl gly glyc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 , 1 10 1 0 0 0 1
measured by measured m me mea meas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 - 1 8 1 0 0 0 1
chromatography-tandem mass chromatography-tandem c ch chr chro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 -., 3 8 1 0 0 0 1
high abundance high h hi hig high BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 0 ()- 3 9 1 0 0 0 1
lines was lines l li lin line BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 , 1 9 1 0 0 0 1
high expression high h hi hig high BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 0 -/ 2 8 1 0 0 0 1
sialylation. Moreover, sialylation. s si sia sial BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 .,- 3 9 1 0 0 0 1
sylation features sylation s sy syl syla BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 no 0 9 1 0 0 0 1
glycans, such glycans, g gl gly glyc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 ,(). 4 9 1 0 0 0 1
Integration of integration I In Int Inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 0 0 no 0 8 1 0 0 0 1
revealed positive revealed r re rev reve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ()- 3 9 1 0 0 0 1
gens, the gens, g ge gen gens BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 , 1 8 1 0 0 0 1
transcription factors transcription t tr tra tran BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ,,/,, 5 8 1 0 0 0 1
MYB. This myb. M MY MYB MYB. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 . 1 9 1 0 0 0 1
factors in factors f fa fac fact BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 (), 3 8 1 0 0 0 1
particularly on particularly p pa par part BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ,/ 2 8 1 0 0 0 1
expression in expression e ex exp expr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 -., 3 10 1 0 0 0 1
provides insights provides p pr pro prov BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 9 1 0 0 0 1
CRC and crc C CR CRC CRC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 no 0 8 1 0 0 0 1
diagnostic and diagnostic d di dia diag BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 . 1 6 1 0 0 0 1
Based on based B Ba Bas Base BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 4 , 1 8 1 0 0 0 1
colorectal cancer colorectal c co col colo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 4 () 2 9 1 0 0 0 1
diagnosed cancer diagnosed d di dia diag BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 (.) 3 9 1 0 0 0 1
cancer death cancer c ca can canc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 (.)(). 6 10 1 0 0 0 1
cancer include cancer c ca can canc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 ,,. 3 10 1 0 0 0 1
molecular targeting molecular m mo mol mole BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 no 0 9 1 0 0 0 1
clinical practice, clinical c cl cli clin BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 ,() 3 9 1 0 0 0 1
monoclonal antibodies monoclonal m mo mon mono BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 5 ()., 4 9 1 0 0 0 1
cases, these cases, c ca cas case BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 , 1 8 1 0 0 0 1
tumor heterogeneity tumor t tu tum tumo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 (). 3 8 1 0 0 0 1
Hence, new hence, H He Hen Henc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 5 ,. 2 7 1 0 0 0 1
Glycosylation has glycosylation G Gl Gly Glyc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 5 no 0 8 1 0 0 0 1
new biomarkers new n ne new new BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 , 1 8 1 0 0 0 1
as an as a as as as BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 no 0 8 1 0 0 0 1
development and development d de dev deve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 5 , 1 7 1 0 0 0 1
angiogenesis, invasion, angiogenesis, a an ang angi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 5 ,,(). 5 8 1 0 0 0 1
contribute to contribute c co con cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 no 0 7 1 0 0 0 1
including (i) including i in inc incl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 ()() 4 9 1 0 0 0 1
(6-9), (ii) (6-9), ( (6 (6- (6-9 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 5 (-),()(),()- 12 9 1 0 0 0 1
localization of localization l lo loc loca BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 5 (,), 4 9 1 0 0 0 1
(iv) the (iv) ( (i (iv (iv) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 5 ()(). 5 8 1 0 0 0 1
Common cancer-associated common C Co Com Comm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 5 - 1 8 1 0 0 0 1
alterations in alterations a al alt alte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 (,). 4 10 1 0 0 0 1
which, the which, w wh whi whic BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 ,,, 3 9 1 0 0 0 1
signaling (5). signaling s si sig sign BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 5 (). 3 8 1 0 0 0 1
results in results r re res resu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 5 - 1 8 1 0 0 0 1
linked to linked l li lin link BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 no 0 8 1 0 0 0 1
extracellular matrix extracellular e ex ext extr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 5 ,, 2 8 1 0 0 0 1
laminin in laminin l la lam lami BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 5 no 0 8 1 0 0 0 1
poor survival poor p po poo poor BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 ().- 4 8 1 0 0 0 1
feature is feature f fe fea feat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 -()[ 4 9 1 0 0 0 1
composed of composed c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 (-),(- 6 8 1 0 0 0 1
linked), fucose linked), l li lin link BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 5 ),(-),-] 8 8 1 0 0 0 1
which is which w wh whi whic BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 no 0 9 1 0 0 0 1
molecules involved molecules m mo mol mole BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 no 0 9 1 0 0 0 1
formation of formation f fo for form BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 .- 2 8 1 0 0 0 1
sion of sion s si sio sion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 5 no 0 9 1 0 0 0 1
CRC patients crc C CR CRC CRC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 5 ().-- 5 8 1 0 0 0 1
markers for markers m ma mar mark BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 ,, 2 8 1 0 0 0 1
carbohydrate antigens carbohydrate c ca car carb BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 () 2 8 1 0 0 0 1
Form the form F Fo For Form BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 10 ,,,; 4 10 1 1 0 0 1
Molecular Medicine, molecular M Mo Mol Mole BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 10 ,,,,; 5 8 1 1 0 0 1
Biochemistry, Groningen biochemistry, B Bi Bio Bioc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 10 ,,,, 4 7 1 1 0 0 1
* For * * * * * BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 10 *:,.@.. 7 4 1 1 0 0 1
RESEARCH RESEARCH research R RE RES RESE BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 1 1 0 0 0 0 0 1 11 no 0 10 1 1 0 0 0
Mol Cell mol M Mo Mol Mol BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 11 ()() 4 10 1 1 0 0 1
© 2024 © © © © © BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 11 .. 2 10 1 1 0 0 1
This is this T Th Thi This BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 11 (://.///./). 12 8 1 1 0 0 1
https://doi.org/10.1016/j.mcpro.2024.100776 https://doi.org/10.1016/j.mcpro.2024.100776 https://doi.org/10.1016/j.mcpro.2024.100776 h ht htt http BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 1 11 ://././... 10 3 1 1 0 0 1
(also known (also ( (a (al (als BLOCKSTART PAGESTART SAMEFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 (- 2 9 0 0 0 0 1
is β1-3 is i is is is BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 --)()- 6 8 0 0 0 0 1
noembryonic antigen noembryonic n no noe noem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 (,)., 5 8 0 0 0 0 1
these biomarkers these t th the thes BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 9 0 0 0 0 1
cancer cells cancer c ca can canc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 - 1 8 0 0 0 0 1
eases (19). eases e ea eas ease BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 (). 3 1 0 0 0 0 1
Many glycosylation many M Ma Man Many BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 1 0 - 1 8 0 0 0 0 1
teins and teins t te tei tein BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 , 1 8 0 0 0 0 1
common features common c co com comm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 , 1 8 0 0 0 0 1
exploration should exploration e ex exp expl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 9 0 0 0 0 1
shared features shared s sh sha shar BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 . 1 8 0 0 0 0 1
knowledge will knowledge k kn kno know BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 - 1 7 0 0 0 0 1
associated glycans associated a as ass asso BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 8 0 0 0 0 1
CRC. CRC. crc. C CR CRC CRC. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 . 1 0 0 0 0 0 1
On the on O On On On BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 8 0 0 0 0 1
expression, CRC expression, e ex exp expr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 , 1 8 0 0 0 0 1
groups, which groups, g gr gro grou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ,- 2 8 0 0 0 0 1
gastrointestinal differentiation gastrointestinal g ga gas gast BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 no 0 9 0 0 0 0 1
cell lines cell c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 8 0 0 0 0 1
epithelial-mesenchymal transition epithelial-mesenchymal e ep epi epit BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 -()().- 7 8 0 0 0 0 1
trometry (MS) trometry t tr tro trom BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 ()-- 4 8 0 0 0 0 1
terization of terization t te ter teri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 no 0 8 0 0 0 0 1
study the study s st stu stud BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 , 1 8 0 0 0 0 1
(21-23). Just (21-23). ( (2 (21 (21- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 (-).,-- 7 8 0 0 0 0 1
glycosylation (22, glycosylation g gl gly glyc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 (,)() 5 8 0 0 0 0 1
glycosylation profiles glycosylation g gl gly glyc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 (), 3 8 0 0 0 0 1
graphitized carbon graphitized g gr gra grap BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 -/. 3 7 0 0 0 0 1
Striking differences striking S St Str Stri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 -- 2 8 0 0 0 0 1
differentiated cell differentiated d di dif diff BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 . 1 10 0 0 0 0 1
to O-glycosylation, to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 -,-- 4 8 0 0 0 0 1
sion of sion s si sio sion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 -/-, 4 9 0 0 0 0 1
undifferentiated cell undifferentiated u un und undi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 - 1 8 0 0 0 0 1
lence of lence l le len lenc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 -, 2 8 0 0 0 0 1
undifferentiated cell undifferentiated u un und undi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 - 1 8 0 0 0 0 1
cans with cans c ca can cans BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 (,,)().- 8 8 0 0 0 0 1
glycans, colon-like glycans, g gl gly glyc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 ,- 2 9 0 0 0 0 1
sulfation, (s)Le sulfation, s su sul sulf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 ,()/,/,,- 9 9 0 0 0 0 1
dic, and dic, d di dic dic, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 ,--, 4 8 0 0 0 0 1
lines highly lines l li lin line BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ,,- 3 8 0 0 0 0 1
sialylation, as sialylation, s si sia sial BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 ,--- 4 8 0 0 0 0 1
cans carrying cans c ca can cans BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ()(-) 5 8 0 0 0 0 1
(22). When (22). ( (2 (22 (22) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 ().,()/ 7 9 0 0 0 0 1
X and x X X X X BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 0 /- 2 9 0 0 0 0 1
undifferentiated cell undifferentiated u un und undi BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 4 - 1 9 1 0 0 0 1
cans with cans c ca can cans BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 (,,)(). 7 8 1 0 0 0 1
In regard in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 1 4 ,- 2 8 1 0 0 0 1
sialic acid sialic s si sia sial BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 4 -()- 4 9 1 0 0 0 1
(24), while (24), ( (2 (24 (24) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 4 (),/- 5 8 1 0 0 0 1
lylation of lylation l ly lyl lyla BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 4 (,).- 5 9 1 0 0 0 1
cans synthesized cans c ca can cans BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 (- 2 8 1 0 0 0 1
FUT11), previous fut11), F FU FUT FUT1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 4 ), 2 9 1 0 0 0 1
sLe X sle s sL sLe sLe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 4 , 1 9 1 0 0 0 1
plays an plays p pl pla play BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 no 0 10 1 0 0 0 1
cell leukemia cell c ce cel cell BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 (,)., 5 10 1 0 0 0 1
fucosyltransferase(s) contribute fucosyltransferase(s) f fu fuc fuco BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 5 ()- 3 9 0 0 0 0 1
gens in gens g ge gen gens BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 5 no 0 8 0 0 0 0 1
are shared are a ar are are BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 . 1 6 0 0 0 0 1
In the in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 1 5 , 1 9 0 0 0 0 1
commonalities and commonalities c co com comm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 5 - 1 9 0 0 0 0 1
entiation-and cancer-associated entiation-and e en ent enti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 5 -- 2 8 0 0 0 0 1
CRC cell crc C CR CRC CRC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 5 ., 2 9 0 0 0 0 1
CRC cell crc C CR CRC CRC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 5 no 0 9 0 0 0 0 1
transcription factors transcription t tr tra tran BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 ()., 4 9 0 0 0 0 1
insights into insights i in ins insi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 (-) 3 10 0 0 0 0 1
CRC across crc C CR CRC CRC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 5 , 1 9 0 0 0 0 1
with potential with w wi wit with BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 . 1 8 0 0 0 0 1
MATERIALS AND materials M MA MAT MATE BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 1 6 no 0 10 0 0 0 0 1
Our recent our O Ou Our Our BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 7 - 1 8 0 0 0 0 1
profiling (N-, profiling p pr pro prof BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 7 (-,-,)(-). 10 9 0 0 0 0 1
Glycomics data glycomics G Gl Gly Glyc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 7 (): 3 9 0 0 0 0 1
GPST000239 (GSL gpst000239 G GP GPS GPST BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 7 ()(),(-)(), 11 8 0 0 0 0 1
GPST000302 (N-glycan) gpst000302 G GP GPS GPST BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 7 (-)(). 6 9 0 0 0 0 1
lines is lines l li lin line BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 7 . 1 9 0 0 0 0 1
available data, available a av ava avai BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 7 ,- 2 9 0 0 0 0 1
tures as tures t tu tur ture BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 7 --,-, 5 9 0 0 0 0 1
and GSL and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 7 ,.- 3 9 0 0 0 0 1
comics data comics c co com comi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 7 (-,-, 5 9 0 0 0 0 1
glycosylation) were glycosylation) g gl gly glyc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 7 ).-(,,) 7 9 0 0 0 0 1
datasets of datasets d da dat data BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 7 no 0 9 0 0 0 0 1
cell lines cell c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 7 . 1 9 0 0 0 0 1
were retrieved were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 7 (). 3 8 0 0 0 0 1
Colon-like cell colon-like C Co Col Colo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 7 -- 2 9 0 0 0 0 1
intestinal differentiation intestinal i in int inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 7 , 1 9 0 0 0 0 1
exhibited an exhibited e ex exh exhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 7 no 0 9 0 0 0 0 1
factor β factor f fa fac fact BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 7 (). 3 10 0 0 0 0 1
in "R" in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 1 7 ""(..)"","","- 14 9 0 0 0 0 1
thods", "stringi", thods", t th tho thod BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 7 ","","","","","","- 19 9 0 0 0 0 1
Heatmap", and heatmap", H He Hea Heat BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 7 ","". 5 3 0 0 0 0 1
Experimental Design experimental E Ex Exp Expe BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 9 no 0 10 0 0 0 0 1
We combined we W We We We BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 9 -,-, 4 9 0 0 0 0 1
have been have h ha hav have BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 9 no 0 8 0 0 0 0 1
chromatography-MS/MS for chromatography-ms/ms c ch chr chro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 9 -/(-). 6 9 0 0 0 0 1
More information more M Mo Mor More BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 9 no 0 9 0 0 0 0 1
Tables S2-S5. tables T Ta Tab Tabl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 2 9 -.,- 4 9 0 0 0 0 1
mined within mined m mi min mine BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 9 -,-, 4 8 0 0 0 0 1
summed, thereby summed, s su sum summ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 9 ,, 2 9 0 0 0 0 1
traits. The traits. t tr tra trai BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 9 . 1 10 0 0 0 0 1
Gene Expression gene G Ge Gen Gene BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 2 9 (). 3 9 0 0 0 0 1
analysis, a analysis, a an ana anal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 9 ,(.) 4 9 0 0 0 0 1
missing data. missing m mi mis miss BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 9 . 1 8 0 0 0 0 1
glycosylation features glycosylation g gl gly glyc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 9 no 0 10 0 0 0 0 1
glycosylation features glycosylation g gl gly glyc BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 9 . 1 9 0 0 0 0 1
RESULTS RESULTS results R RE RES RESU BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 1 0 0 0 0 0 2 11 no 0 10 1 0 0 0 1
Integrated glycosylation integrated I In Int Inte BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 11 no 0 9 1 1 0 0 1
the differentiation the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 11 , 1 10 1 1 0 0 1
molecular alteration molecular m mo mol mole BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 11 - 1 8 1 1 0 0 1
mors and mors m mo mor mors BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 11 no 0 9 1 1 0 0 1
CRC (20, crc C CR CRC CRC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 11 (,,). 5 8 1 1 0 0 1
glycosylation of glycosylation g gl gly glyc BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 11 no 0 7 1 1 0 0 1
(Sialyl)Lewis Antigen (sialyl)lewis ( (S (Si (Sia BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 11 ()- 3 10 0 1 0 0 0
Mol Cell mol M Mo Mol Mol BLOCKSTART PAGEEND NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 11 ()() 4 10 1 1 1 1 1
tumor-associated glycosylation tumor-associated t tu tum tumo BLOCKSTART PAGESTART NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 -, 2 9 1 0 0 0 1
features on features f fe fea feat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 -,-, 4 9 1 0 0 0 1
integrated based integrated i in int inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 9 1 0 0 0 1
study (supplemental study s st stu stud BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 (). 3 9 1 0 0 0 1
lines were lines l li lin line BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 8 1 0 0 0 1
(Fig. 1A) (fig. ( (F (Fi (Fig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 (.) 3 10 1 0 0 0 1
features (Fig. features f fe fea feat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 (.). 4 3 1 0 0 0 1
Colon-like cell colon-like C Co Col Colo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 -(,,,, 6 8 1 0 0 0 1
SW948, and sw948, S SW SW9 SW94 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 0 ,)()/ 5 9 1 0 0 0 1
and Le and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 /(-,-,),/(- 11 9 1 0 0 0 1
glycan), and glycan), g gl gly glyc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 ),()/(-)(.). 12 9 1 0 0 0 1
highest abundance highest h hi hig high BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 /-,-, 5 9 1 0 0 0 1
was found was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 (,,,) 5 9 1 0 0 0 1
and LS174T and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 (,,,)( 6 8 1 0 0 0 1
Fig. S2 fig. F Fi Fig Fig. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 .)./,- 6 9 1 0 0 0 1
dance of dance d da dan danc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 / 1 8 1 0 0 0 1
LS174T for ls174t L LS LS1 LS17 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 0 (. 2 9 1 0 0 0 1
Table S6). table T Ta Tab Tabl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 ).,/- 5 9 1 0 0 0 1
expressed in expressed e ex exp expr BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 8 1 0 0 0 1
quantification of quantification q qu qua quan BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 4 ..,.. 5 8 1 0 0 0 1
of relative of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 /- 2 10 1 0 0 0 1
lines LS180 lines l li lin line BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 .- 2 8 1 0 0 0 1
sion of sion s si sio sion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 4 /- 2 9 1 0 0 0 1
(unassigned). The (unassigned). ( (u (un (una BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 4 ().(/)/( 8 9 1 0 0 0 1
structure structure structure s st str stru BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 no 0 1 1 0 0 0 1
GalNAcα1-3(Fucα1-2) GalNAcα1-3(Fucα1-2) galnacα1-3(fucα1-2) G Ga Gal GalN BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 4 -(-) 4 2 1 0 0 0 1
Galβ1-3/4(Fucα1-4/3) Galβ1-3/4(Fucα1-4/3) galβ1-3/4(fucα1-4/3) G Ga Gal Galβ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 4 -/(-/) 6 3 1 0 0 0 1
GlcNAc-R for glcnac-r G Gl Glc GlcN BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 4 -/-(-)-/(- 10 8 1 0 0 0 1
4/3) GlcNAc-R 4/3) 4 4/ 4/3 4/3) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 4 /)-/) 5 8 1 0 0 0 1
the well-differentiated the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 -(. 3 9 1 0 0 0 1
and Table and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 ). 2 2 1 0 0 0 1
In regard in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 2 4 ,-/ 3 9 1 0 0 0 1
three glycan three t th thr thre BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 - 1 8 1 0 0 0 1
differentiated cell differentiated d di dif diff BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 ,-,, 4 8 1 0 0 0 1
well as well w we wel well BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 ,,, 3 9 1 0 0 0 1
SW1398 (Fig. sw1398 S SW SW1 SW13 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 2 4 (.).- 5 8 1 0 0 0 1
highest α2-3 highest h hi hig high BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 --. 3 8 1 0 0 0 1
HCT8 (unassigned hct8 H HC HCT HCT8 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 4 ()- 3 8 1 0 0 0 1
tered together tered t te ter tere BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 4 , 1 8 1 0 0 0 1
LOVO, HCT15, lovo, L LO LOV LOVO BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 4 ,,-, 4 8 1 0 0 0 1
FIG. 1. fig. F FI FIG FIG. BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 2 9 ..()-,-,., 10 9 1 1 0 0 1
score plot score s sc sco scor BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 9 (),-,- 6 10 1 1 0 0 1
glycans, and glycans, g gl gly glyc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 9 ,().. 5 9 1 1 0 0 1
two principal two t tw two two BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 9 ., 2 9 1 1 0 0 1
69% was 69% 6 69 69% 69% BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 9 (.).,;,. 8 6 1 1 0 0 1
(Sialyl)Lewis Antigen (sialyl)lewis ( (S (Si (Sia BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 11 ()- 3 10 0 1 0 0 0
3 Mol 3 3 3 3 3 BLOCKSTART PAGEEND NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 2 11 ()() 4 10 1 1 1 0 1
of blood of o of of of BLOCKSTART PAGESTART SAMEFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 -,-, 4 9 0 0 0 0 1
(Fig. 1). (fig. ( (F (Fi (Fig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 (.).- 5 9 0 0 0 0 1
gens on gens g ge gen gens BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 -, 2 9 0 0 0 0 1
highest expression highest h hi hig high BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 - 1 9 0 0 0 0 1
found in found f fo fou foun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 -()(. 5 10 0 0 0 0 1
Table S6). table T Ta Tab Tabl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 ). 2 9 0 0 0 0 1
glycans, the glycans, g gl gly glyc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 ,- 2 9 0 0 0 0 1
tiated cell tiated t ti tia tiat BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 (). 3 4 0 0 0 0 1
Correlation of correlation C Co Cor Corr BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 10 0 0 0 0 1
Classes Classes classes C Cl Cla Clas BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 1 0 0 0 0 1
Next, the next, N Ne Nex Next BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 1 , 1 8 0 0 0 0 1
three glycan three t th thr thre BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 1 . 1 9 0 0 0 0 1
were observed were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 1 -- 2 8 0 0 0 0 1
glycans classes glycans g gl gly glyc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 1 (.). 4 8 0 0 0 0 1
revealed between revealed r re rev reve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 1 - 1 8 0 0 0 0 1
gens as gens g ge gen gens BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 1 /(.)., 6 8 0 0 0 0 1
explored the explored e ex exp expl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 1 no 0 9 0 0 0 0 1
line classifications line l li lin line BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 1 (.).()/ 7 10 0 0 0 0 1
X and x X X X X BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 1 (/)/ 4 9 0 0 0 0 1
colon-like cell colon-like c co col colo BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 -.,- 4 10 0 0 0 0 1
3/6 sialylation 3/6 3 3/ 3/6 3/6 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 2 /---. 5 9 0 0 0 0 1
In contrast, in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 3 2 ,- 2 8 0 0 0 0 1
glycans were glycans g gl gly glyc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 2 no 0 9 0 0 0 0 1
(supplemental Table (supplemental ( (s (su (sup BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 2 (.). 4 5 0 0 0 0 1
Correlation of correlation C Co Cor Corr BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 2 no 0 10 0 0 0 0 1
Lines Lines lines L Li Lin Line BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 2 no 0 1 0 0 0 0 1
To explore to T To To To BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 2 no 0 8 1 0 0 0 1
glycosylation features glycosylation g gl gly glyc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 2 ,- 2 8 1 0 0 0 1
tween glycosylation tween t tw twe twee BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 2 no 0 8 1 0 0 0 1
explored by explored e ex exp expl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 (). 3 8 1 0 0 0 1
GT FUT2, gt G GT GT GT BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 2 , 1 8 1 0 0 0 1
catalyzing the catalyzing c ca cat cata BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 2 - 1 9 1 0 0 0 1
both N-and both b bo bot both BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 ---(, 5 8 1 0 0 0 1
33), significantly 33), 3 33 33) 33), BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 2 ),(/)/ 6 9 1 0 0 0 1
and integrated and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 (/)/( 5 9 1 0 0 0 1
the (A/B) the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 (/)/-,-, 8 9 1 0 0 0 1
glycans) (Fig. glycans) g gl gly glyc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 2 )(.)., 6 9 1 0 0 0 1
found between found f fo fou foun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 / 1 8 1 0 0 0 1
unexpected as unexpected u un une unex BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 no 0 8 1 0 0 0 1
Le A/X le L Le Le Le BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 3 2 /., 3 8 1 0 0 0 1
transfer of transfer t tr tra tran BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 --/-/ 5 9 1 0 0 0 1
linkage to linkage l li lin link BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 /// 3 9 1 0 0 0 1
structures (25, structures s st str stru BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 (,-),/- 7 9 1 0 0 0 1
glycan, GSL, glycan, g gl gly glyc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 2 ,,,/-, 6 8 1 0 0 0 1
GSL, and gsl, G GS GSL GSL, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 2 ,,()// 6 9 1 0 0 0 1
on O-glycans on o on on on BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 -(/)/- 6 8 1 0 0 0 1
tegrated glycans tegrated t te teg tegr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 2 (.).,- 6 9 1 0 0 0 1
thesis of thesis t th the thes BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 ()- 3 9 1 0 0 0 1
type 2 type t ty typ type BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 --(-), 6 9 1 0 0 0 1
correlated with correlated c co cor corr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 ()/(.). 7 9 1 0 0 0 1
FUT5, also fut5, F FU FUT FUT5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 2 ,() 3 9 1 0 0 0 1
Le X le L Le Le Le BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 3 2 (-),() 6 10 1 0 0 0 1
Le X le L Le Le Le BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 3 6 (.). 4 9 0 0 0 0 1
the formation the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 ()(,) 5 9 0 0 0 0 1
correlated with correlated c co cor corr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 /()/- 5 10 0 0 0 0 1
well as well w we wel well BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 /-.,,- 6 8 0 0 0 0 1
lyzes the lyzes l ly lyz lyze BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 6 - 1 9 0 0 0 0 1
α1-6 linkage α1-6 α α1 α1- α1-6 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 6 -(),-- 6 9 0 0 0 0 1
cans (Fig. cans c ca can cans BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 (.). 4 2 0 0 0 0 1
ST3GAL1, participating st3gal1, S ST ST3 ST3G BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 6 ,- 2 8 0 0 0 0 1
lylation of lylation l ly lyl lyla BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 6 -(), 4 9 0 0 0 0 1
positively correlated positively p po pos posi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 -- 2 9 0 0 0 0 1
integrated α2-3 integrated i in int inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 -(.)., 6 9 0 0 0 0 1
correlation was correlation c co cor corr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 //-- 4 8 0 0 0 0 1
lation in lation l la lat lati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 6 (.),- 5 9 0 0 0 0 1
what unexpected what w wh wha what BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 no 0 8 0 0 0 0 1
involved in involved i in inv invo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 - 1 9 0 0 0 0 1
and glycolipids and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 (,)., 5 9 0 0 0 0 1
be primarily be b be be be BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 - 1 9 0 0 0 0 1
globo series globo g gl glo glob BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 6 (,),- 5 9 0 0 0 0 1
relation with relation r re rel rela BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 - 1 9 0 0 0 0 1
showed a showed s sh sho show BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 --- 3 9 0 0 0 0 1
cans (Fig. cans c ca can cans BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 (.)., 5 8 0 0 0 0 1
addition of addition a ad add addi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 - 1 9 0 0 0 0 1
sides (51) sides s si sid side BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 3 6 ()-- 4 9 0 0 0 0 1
lylation on lylation l ly lyl lyla BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 6 (.). 4 5 0 0 0 0 1
ST6GALNAC1-4 is st6galnac1-4 S ST ST6 ST6G BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 6 - 1 8 0 0 0 0 1
GalNAc of galnac G Ga Gal GalN BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 6 -() 3 9 0 0 0 0 1
with α2-6 with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 --./ 4 8 0 0 0 0 1
to transfer to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 -(, 3 9 0 0 0 0 1
26), and 26), 2 26 26) 26), BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 6 ),,- 4 9 0 0 0 0 1
sialylation on sialylation s si sia sial BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 6 (.)., 5 9 0 0 0 0 1
transferring a transferring t tr tra tran BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 - 1 8 0 0 0 0 1
substrates mainly substrates s su sub subs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 6 -(,), 5 8 0 0 0 0 1
showed no showed s sh sho show BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 ---- 4 9 0 0 0 0 1
cans and cans c ca can cans BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 no 0 9 0 0 0 0 1
with integrated with w wi wit with BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 -(.). 5 6 0 0 0 0 1
Association of association A As Ass Asso BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 9 no 0 10 0 0 0 0 1
Glycosylation Features glycosylation G Gl Gly Glyc BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 9 no 0 8 0 0 0 0 1
To obtain to T To To To BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 10 no 0 8 1 0 0 0 1
expression of expression e ex exp expr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 10 , 1 9 1 0 0 0 1
difference in difference d di dif diff BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 10 -- 2 9 1 0 0 0 1
ated cell ated a at ate ated BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 10 no 0 9 1 0 0 0 1
GTs (23). gts G GT GTs GTs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 10 ().,,, 6 8 1 0 0 0 1
HNF4A, MECOM, hnf4a, H HN HNF HNF4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 ,,- 3 8 1 0 0 0 1
lines whereas lines l li lin line BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 10 , 1 8 1 0 0 0 1
MSX1, SIX4, msx1, M MS MSX MSX1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 ,,, 3 8 1 0 0 0 1
undifferentiated cell undifferentiated u un und undi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 10 ().,, 5 10 1 0 0 0 1
and corresponding and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 10 no 0 9 1 0 0 0 1
the Spearman the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 10 (). 3 6 1 0 0 0 1
The correlation the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 10 no 0 8 1 0 0 0 1
with TFs with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 10 ,,,, 4 8 1 0 0 0 1
correlated with correlated c co cor corr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 10 (/)/()(/) 9 9 1 0 0 0 1
Le B/Y le L Le Le Le BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 3 10 /(.)., 6 9 1 0 0 0 1
with TF with w wi wit with BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 10 . 1 8 1 0 0 0 1
(Sialyl)Lewis Antigen (sialyl)lewis ( (S (Si (Sia BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 11 ()- 3 10 0 1 0 0 0
Mol Cell mol M Mo Mol Mol BLOCKSTART PAGEEND NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 11 ()() 4 10 1 1 1 0 1
correlations with correlations c co cor corr BLOCKSTART PAGESTART NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 .,/ 3 10 1 0 0 0 1
glycans and glycans g gl gly glyc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 /- 2 9 1 0 0 0 1
rections with rections r re rec rect BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 ,,,, 4 8 1 0 0 0 1
negative correlations negative n ne neg nega BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 ,,,, 4 9 1 0 0 0 1
and ZNF286B and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 ,, 2 8 1 0 0 0 1
expressed in expressed e ex exp expr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 . 1 9 1 0 0 0 1
positive correlation positive p po pos posi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 /-(.).- 7 10 1 0 0 0 1
tionally, ETS2, tionally, t ti tio tion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 ,,,- 4 9 1 0 0 0 1
tions with tions t ti tio tion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 /(-,,) 6 9 1 0 0 0 1
which negatively which w wh whi whic BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 ,, 2 8 1 0 0 0 1
ZNF286B (Fig. znf286b Z ZN ZNF ZNF2 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 3 (.).- 5 9 1 0 0 0 1
relation with relation r re rel rela BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 3 (.). 4 9 1 0 0 0 1
Regarding the regarding R Re Reg Rega BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 3 , 1 9 1 0 0 0 1
ST6GALNAC1 positively st6galnac1 S ST ST6 ST6G BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 3 ,, 2 8 1 0 0 0 1
and MECOM, and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 3 ,- 2 8 1 0 0 0 1
tween ST6GALNAC6 tween t tw twe twee BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 3 ,,(.). 6 8 1 0 0 0 1
TFs MSX1, tfs T TF TFs TFs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 3 ,,- 3 8 1 0 0 0 1
lations with lations l la lat lati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 3 -- 2 10 1 0 0 0 1
ST6GALNAC1, while st6galnac1, S ST ST6 ST6G BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 3 , 1 9 1 0 0 0 1
with ST6GALNAC6 with w wi wit with BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 3 (.). 4 4 1 0 0 0 1
FIG. 2. fig. F FI FIG FIG. BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 4 6 ..-,- 5 8 1 0 0 0 1
glycans, and glycans, g gl gly glyc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 6 ,()()., 7 9 1 0 0 0 1
three glycan three t th thr thre BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 6 .*(.),**(.),***(.)., 20 10 1 0 0 0 1
three classifications three t th thr thre BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 6 .-,-, 5 9 1 0 0 0 1
used as used u us use used BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 6 .,,.,;, 7 9 1 0 0 0 1
glycosphingolipid. glycosphingolipid. glycosphingolipid. g gl gly glyc BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 6 . 1 1 1 0 0 0 1
(Sialyl)Lewis Antigen (sialyl)lewis ( (S (Si (Sia BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 11 ()- 3 10 1 1 0 0 0
5 Mol 5 5 5 5 5 BLOCKSTART PAGEEND NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 4 11 ()() 4 10 1 1 1 0 1
FIG. 3. fig. F FI FIG FIG. BLOCKSTART PAGESTART SAMEFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 4 0 ..-,-,., 8 9 1 1 0 0 1
with (s)Le with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 ().,. 5 10 1 1 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 . 1 9 1 1 0 0 1
with * with w wi wit with BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 *(.),**(.),***(.).,;,. 22 7 1 1 0 0 1
(Sialyl)Lewis Antigen (sialyl)lewis ( (S (Si (Sia BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 9 ()- 3 10 1 1 0 0 0
Mol Cell mol M Mo Mol Mol BLOCKSTART PAGEEND NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 10 ()() 4 10 1 1 1 0 1
DISCUSSION DISCUSSION discussion D DI DIS DISC BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 10 1 1 0 0 1
We recently we W We We We BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 0 --,-, 5 9 1 1 0 0 1
GSL glycomic gsl G GS GSL GSL BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 no 0 10 1 1 0 0 1
commonalities as commonalities c co com comm BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 1 no 0 10 1 1 0 0 1
(20, 21, (20, ( (2 (20 (20, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 1 (,,). 5 9 1 1 0 0 1
expression patterns expression e ex exp expr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 1 no 0 9 1 1 0 0 1
the three the t th the the BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 1 no 0 9 1 1 0 0 1
FIG. 4. fig. F FI FIG FIG. BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 4 3 ..-,-, 6 9 1 0 0 0 1
lines. A, lines. l li lin line BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 3 .,,(),., 8 10 1 0 0 0 1
GTs. The gts. G GT GTs GTs. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 3 .. 2 9 1 0 0 0 1
values are values v va val valu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 3 *(.),**(.),***(.)****(.).,;,;, 30 9 1 0 0 0 1
glycosyltransferase; TF, glycosyltransferase; g gl gly glyc BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 3 ;,. 3 3 1 0 0 0 1
(Sialyl)Lewis Antigen (sialyl)lewis ( (S (Si (Sia BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 10 ()- 3 10 1 1 0 0 0
7 Mol 7 7 7 7 7 BLOCKSTART PAGEEND NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 4 11 ()() 4 10 1 1 1 0 1
how these how h ho how how BLOCKSTART PAGESTART SAMEFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 8 1 0 0 0 1
differentiation pattern differentiation d di dif diff BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 , 1 8 1 0 0 0 1
available data available a av ava avai BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 9 1 0 0 0 1
features (supplemental features f fe fea feat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 (-). 4 8 1 0 0 0 1
CRC classifications crc C CR CRC CRC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 no 0 8 1 0 0 0 1
features across features f fe fea feat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 9 1 0 0 0 1
(s)Le A/X (s)le ( (s (s) (s)L BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 ()/-(.), 8 10 1 0 0 0 1
cell line cell c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 (). 3 9 1 0 0 0 1
study suggested study s st stu stud BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 , 1 8 1 0 0 0 1
only the only o on onl only BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 (-/)- 5 8 1 0 0 0 1
their mucin their t th the thei BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 - 1 8 1 0 0 0 1
ride chains, ride r ri rid ride BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 ,(), 4 8 1 0 0 0 1
result from result r re res resu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 9 1 0 0 0 1
signatures. Due signatures. s si sig sign BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 ., 2 9 1 0 0 0 1
might be might m mi mig migh BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 8 1 0 0 0 1
tumor. tumor. tumor. t tu tum tumo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 . 1 1 1 0 0 0 1
The sLe the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 0 / 1 8 1 0 0 0 1
typical tumor-associated typical t ty typ typi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 -- 2 8 1 0 0 0 1
gression (4, gression g gr gre gres BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 (,,,).,- 8 9 1 0 0 0 1
sion of sion s si sio sion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 ()/ 3 8 1 0 0 0 1
which sLe which w wh whi whic BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 ,-, 3 8 1 0 0 0 1
a mouse a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 4 0 (---)(-). 9 7 1 0 0 0 1
Nowadays, CA19-9 nowadays, N No Now Nowa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 0 ,- 2 8 1 0 0 0 1
CRC and crc C CR CRC CRC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 no 0 7 1 0 0 0 1
prognosis (16-18). prognosis p pr pro prog BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 (-)., 5 8 1 0 0 0 1
shows associations shows s sh sho show BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 , 1 8 1 0 0 0 1
incidence of incidence i in inc inci BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 (-). 4 9 1 0 0 0 1
levels of levels l le lev leve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 -,-, 4 8 1 0 0 0 1
glycans in glycans g gl gly glyc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 (-) 3 8 1 0 0 0 1
colon-like cell colon-like c co col colo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 - 1 9 1 0 0 0 1
(s)Le A/X (s)le ( (s (s) (s)L BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 ()/(.).- 8 9 1 0 0 0 1
ing the ing i in ing ing BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 4 0 , 1 9 1 0 0 0 1
sLe A/X sle s sL sLe sLe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 / 1 9 1 0 0 0 1
differentiated CRC. differentiated d di dif diff BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 . 1 8 1 0 0 0 1
inability to inability i in ina inab BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 9 1 0 0 0 1
abundance of abundance a ab abu abun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 . 1 8 1 0 0 0 1
Le antigens le L Le Le Le BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 4 0 no 0 7 1 0 0 0 1
approaches such approaches a ap app appr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 ., 2 8 1 0 0 0 1
and other and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 - 1 8 1 0 0 0 1
analysis due analysis a an ana anal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 - 1 9 1 0 0 0 1
phase extraction phase p ph pha phas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 -. 2 8 1 0 0 0 1
address this address a ad add addr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 , 1 8 1 0 0 0 1
investigated for investigated i in inv inve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 -. 2 8 1 0 0 0 1
More than more M Mo Mor More BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 0 ,- 2 8 1 0 0 0 1
gen was gen g ge gen gen BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 4 0 - 1 8 1 0 0 0 1
body AH6 body b bo bod body BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 8 1 0 0 0 1
(68), and (68), ( (6 (68 (68) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 (),/- 5 8 1 0 0 0 1
uted to uted u ut ute uted BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 ().,/- 6 9 1 0 0 0 1
gens were gens g ge gen gens BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 no 0 8 1 0 0 0 1
significant association significant s si sig sign BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 (.). 4 9 1 0 0 0 1
study demonstrated study s st stu stud BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 8 1 0 0 0 1
cDNA encoding cdna c cD cDN cDNA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 - 1 7 1 0 0 0 1
tumorigenicity and tumorigenicity t tu tum tumo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 no 0 7 1 0 0 0 1
expression of expression e ex exp expr BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 /(). 4 9 1 0 0 0 1
research reported research r re res rese BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 5 5 no 0 9 1 0 0 0 1
related to related r re rel rela BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 ();, 4 9 1 0 0 0 1
according associations according a ac acc acco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 . 1 8 1 0 0 0 1
Interestingly, FUT2/3 interestingly, I In Int Inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 5 ,/(/) 5 9 1 0 0 0 1
Le B/Y le L Le Le Le BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 5 5 /, 2 9 1 0 0 0 1
observed between observed o ob obs obse BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 //-- 4 8 1 0 0 0 1
glycans (Fig. glycans g gl gly glyc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 5 (.),- 5 8 1 0 0 0 1
strates of strates s st str stra BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 5 // 2 9 1 0 0 0 1
CRC cell crc C CR CRC CRC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 5 . 1 9 1 0 0 0 1
(25, 34, (25, ( (2 (25 (25, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 5 (,,,,,)., 9 9 1 0 0 0 1
the synthesis the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 ///, 4 10 1 0 0 0 1
chain 2 chain c ch cha chai BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 (), 3 9 1 0 0 0 1
disialyl Le disialyl d di dis disi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 5 ,-. 3 10 1 0 0 0 1
between Le between b be bet betw BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 ///,/,()/ 9 9 1 0 0 0 1
(Fig. 3A) (fig. ( (F (Fi (Fig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 5 (.) 3 9 1 0 0 0 1
of CRC of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 ()., 4 8 1 0 0 0 1
lower overall lower l lo low lowe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 (), 3 9 1 0 0 0 1
FUT3 inhibits fut3 F FU FUT FUT3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 5 ,,, 3 9 1 0 0 0 1
TGF-β induced tgf-β T TG TGF TGF- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 5 -().- 5 8 1 0 0 0 1
utes to utes u ut ute utes BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 5 ()(-) 5 9 1 0 0 0 1
to be to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 ()/, 4 9 1 0 0 0 1
interestingly, not interestingly, i in int inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 ,--(.). 7 9 1 0 0 0 1
line with line l li lin line BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 no 0 9 1 0 0 0 1
FUT6 in fut6 F FU FUT FUT6 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 5 (,)., 5 9 1 0 0 0 1
AML cell aml A AM AML AML BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 5 ,()/ 4 9 1 0 0 0 1
positively correlated positively p po pos posi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 /(). 4 8 1 0 0 0 1
hypothesize that hypothesize h hy hyp hypo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 - 1 8 1 0 0 0 1
lated by lated l la lat late BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 5 -- 2 8 1 0 0 0 1
manner. FUT6 manner. m ma man mann BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 .() 3 9 1 0 0 0 1
(43, 44), (43, ( (4 (43 (43, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 5 (,),/() 7 9 1 0 0 0 1
Le A/X le L Le Le Le BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 5 5 /-/-(.). 8 9 1 0 0 0 1
Thus, except thus, T Th Thu Thus BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 5 ,, 2 9 1 0 0 0 1
GTs such gts G GT GTs GTs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 5 // 2 8 1 0 0 0 1
study the study s st stu stud BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 . 1 8 1 0 0 0 1
In addition, in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 5 5 , 1 8 1 0 0 0 1
(especially on (especially ( (e (es (esp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 5 (-)- 4 8 1 0 0 0 1
differentiated cell differentiated d di dif diff BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 (.).- 5 8 1 0 0 0 1
strated that strated s st str stra BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 5 no 0 7 1 0 0 0 1
tumorigenicity of tumorigenicity t tu tum tumo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 5 no 0 8 1 0 0 0 1
progression (79). progression p pr pro prog BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 (). 3 8 1 0 0 0 1
caused by caused c ca cau caus BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 - 1 8 1 0 0 0 1
shown to shown s sh sho show BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 no 0 8 1 0 0 0 1
cancer cell cancer c ca can canc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 (,).- 5 8 1 0 0 0 1
fucosylation as fucosylation f fu fuc fuco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 5 no 0 9 1 0 0 0 1
CRC (80). crc C CR CRC CRC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 5 ().,()- 7 8 1 0 0 0 1
tential as tential t te ten tent BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 5 no 0 9 1 0 0 0 1
vulvar cancer vulvar v vu vul vulv BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 5 ().,, 5 9 1 0 0 0 1
ABO (H) abo A AB ABO ABO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 5 ()-- 4 8 1 0 0 0 1
ciated with ciated c ci cia ciat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 5 no 0 9 1 0 0 0 1
attributed to attributed a at att attr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 - 1 9 1 0 0 0 1
regulation of regulation r re reg regu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 ()(-). 6 9 1 0 0 0 1
study, although study, s st stu stud BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 , 1 9 1 0 0 0 1
blood group blood b bl blo bloo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 (-,- 4 8 1 0 0 0 1
glycans, and glycans, g gl gly glyc BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 5 ,;.), 5 9 1 0 0 0 1
(Sialyl)Lewis Antigen (sialyl)lewis ( (S (Si (Sia BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 11 ()- 3 10 0 1 0 0 0
Mol Cell mol M Mo Mol Mol BLOCKSTART PAGEEND NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 11 ()() 4 10 1 1 1 0 1
was observed was w wa was was BLOCKSTART PAGESTART NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 - 1 7 1 0 0 0 1
fucosyltransferase FUT1 fucosyltransferase f fu fuc fuco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 (.). 4 8 1 0 0 0 1
showed positive showed s sh sho show BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 (/)/ 4 9 1 0 0 0 1
and integrated and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 (/)/(.) 7 9 1 0 0 0 1
reported to reported r re rep repo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 (). 3 9 1 0 0 0 1
breast cancer, breast b br bre brea BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 ,- 2 8 1 0 0 0 1
lating growth, lating l la lat lati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 ,, 2 9 1 0 0 0 1
might serve might m mi mig migh BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 ().- 4 9 1 0 0 0 1
ferentiated stage, ferentiated f fe fer fere BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 , 1 8 1 0 0 0 1
GTs may gts G GT GTs GTs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 . 1 8 1 0 0 0 1
CDX1 as cdx1 C CD CDX CDX1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 - 1 9 1 0 0 0 1
has been has h ha has has BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 (). 3 9 1 0 0 0 1
In our in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 6 0 , 1 9 1 0 0 0 1
lines expressing lines l li lin line BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 no 0 8 1 0 0 0 1
showed a showed s sh sho show BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 (). 3 8 1 0 0 0 1
The correlation the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 no 0 8 1 0 0 0 1
CRC (87, crc C CR CRC CRC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 (,),(/) 7 9 1 0 0 0 1
Le B/Y le L Le Le Le BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 6 0 /(/)/ 5 9 1 0 0 0 1
corresponding GTs corresponding c co cor corr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 (.)., 5 8 1 0 0 0 1
found that found f fo fou foun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 - 1 8 1 0 0 0 1
significantly correlated significantly s si sig sign BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 ()/ 3 9 1 0 0 0 1
(A/B) Le (a/b) ( (A (A/ (A/B BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 (/)/. 5 9 1 0 0 0 1
throughout all throughout t th thr thro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 no 0 9 1 0 0 0 1
to promote to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 (,)., 5 9 1 0 0 0 1
other TFs other o ot oth othe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 no 0 9 1 0 0 0 1
the regulation the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 -() 3 9 1 0 0 0 1
which no which w wh whi whic BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 .,- 3 9 1 0 0 0 1
tive correlations tive t ti tiv tive BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 /(/)/ 5 10 1 0 0 0 1
on GSL on o on on on BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 . 1 8 1 0 0 0 1
When exploring when W Wh Whe When BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 no 0 9 1 0 0 0 1
glycosylation features, glycosylation g gl gly glyc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 ,- 2 9 1 0 0 0 1
ated with ated a at ate ated BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 ()/,(/)/,/ 10 9 1 0 0 0 1
Le A/X le L Le Le Le BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 6 0 /-,/(.). 8 9 1 0 0 0 1
Upregulation of upregulation U Up Upr Upre BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 no 0 9 1 0 0 0 1
prognosis of prognosis p pr pro prog BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 (-)., 5 8 1 0 0 0 1
that high that t th tha that BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 (,,/,, 6 8 1 0 0 0 1
and MYB) and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 )() 3 9 1 0 0 0 1
antigens in antigens a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 -- 2 9 1 0 0 0 1
sponding GT sponding s sp spo spon BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 /.,- 4 8 1 0 0 0 1
ical experiments ical i ic ica ical BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 ., 2 9 1 0 0 0 1
expression of expression e ex exp expr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 no 0 8 1 0 0 0 1
obtain insights obtain o ob obt obta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 - 1 9 1 0 0 0 1
sion. The sion. s si sio sion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 ., 2 9 1 0 0 0 1
however, only however, h ho how howe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 ,. 2 8 1 0 0 0 1
More experiments more M Mo Mor More BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 - 1 8 1 0 0 0 1
binding of binding b bi bin bind BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 no 0 9 1 0 0 0 1
future studies. future f fu fut futu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 . 1 2 1 0 0 0 1
In conclusion, in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 6 0 , 1 8 1 0 0 0 1
glycan classes glycan g gl gly glyc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 . 1 7 1 0 0 0 1
revealed overexpression revealed r re rev reve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 ()- 3 9 1 0 0 0 1
lines on lines l li lin line BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 no 0 8 1 0 0 0 1
blood group blood b bl blo bloo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 no 0 9 1 0 0 0 1
lines. The lines. l li lin line BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 .() 3 8 1 0 0 0 1
antigens on antigens a an ant anti BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 , 1 8 1 0 0 0 1
FUT4/6, instead fut4/6, F FU FUT FUT4 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 /, 2 8 0 0 0 0 1
the main the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 () 2 9 0 0 0 0 1
CRC. In crc. C CR CRC CRC. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 6 .,/ 3 9 0 0 0 0 1
(s)Le antigens (s)le ( (s (s) (s)L BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 6 ()- 3 8 0 0 0 0 1
O-glycans, indicating o-glycans, O O- O-g O-gl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 6 -,/ 3 8 0 0 0 0 1
expression of expression e ex exp expr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 (). 3 8 0 0 0 0 1
discovered relationship discovered d di dis disc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 () 2 8 0 0 0 0 1
antigens and antigens a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 6 no 0 9 0 0 0 0 1
contribute to contribute c co con cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 () 2 10 0 0 0 0 1
of FUT3. of o of of of BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 . 1 1 0 0 0 0 1
DATA AVAILABILITY data D DA DAT DATA BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 6 7 no 0 10 0 0 0 0 1
Glycomics data glycomics G Gl Gly Glyc BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 7 - 1 9 0 0 0 0 1
coPOST: GPST000239 copost: c co coP coPO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 7 :(),(- 6 8 0 0 0 0 1
glycan), and glycan), g gl gly glyc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 7 ),(-). 6 9 0 0 0 0 1
data of data d da dat data BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 7 - 1 10 0 0 0 0 1
sion Omnibus sion s si sio sion BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 7 . 1 3 0 0 0 0 1
Supplemental Data supplemental S Su Sup Supp BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 7 - 1 10 0 0 0 0 1
data (20-23,94) data d da dat data BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 7 (-,) 4 2 0 0 0 0 1
Acknowledgments -We acknowledgments A Ac Ack Ackn BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 8 - 1 8 0 0 0 0 1
Constantin Blöchl constantin C Co Con Cons BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 6 8 . 1 10 0 0 0 0 1
Funding and funding F Fu Fun Fund BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 8 -.. 3 10 0 0 0 0 1
the China the t th the the BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 8 .. 2 10 0 0 0 0 1
Author contributions author A Au Aut Auth BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 8 -..,..,....-.,. 15 9 0 0 0 0 1
W. conceptualization; w. W W. W. W. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 8 .;..;..... 10 9 0 0 0 0 1
software; D. software; s so sof soft BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 8 ;..;..;.... 11 10 0 0 0 0 1
resources; D. resources; r re res reso BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 8 ;..;..-;. 9 10 0 0 0 0 1
W., K. w., W W. W., W., BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 8 .,..,...,....-.,..- 19 9 0 0 0 0 1
editing; D. editing; e ed edi edit BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 8 ;..,..,...,....-.,.. 20 9 0 0 0 0 1
visualization; M. visualization; v vi vis visu BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 8 ;... 4 5 0 0 0 0 1
Conflict of conflict C Co Con Conf BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 9 - 1 10 0 0 0 0 1
interests. interests. interests. i in int inte BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 9 . 1 2 0 0 0 0 1
Abbreviations -The abbreviations A Ab Abb Abbr BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 9 -:,- 4 8 0 0 0 0 1
drate antigen; drate d dr dra drat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 9 ;,;, 4 9 0 0 0 0 1
matrix; EMT, matrix; m ma mat matr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 9 ;,-;,- 6 9 0 0 0 0 1
acetylgalactosamine; GSL, acetylgalactosamine; a ac ace acet BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 9 ;,;,- 5 9 0 0 0 0 1
transferase; sLe transferase; t tr tra tran BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 9 ;,;,. 5 10 0 0 0 0 1
Received November received R Re Rec Rece BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 10 ,,,, 4 9 0 0 0 0 1
Published, MCPRO published, P Pu Pub Publ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 10 ,,,,://./ 9 10 0 0 0 0 1
10.1016/j.mcpro.2024.100776 10.1016/j.mcpro.2024.100776 10.1016/j.mcpro.2024.100776 1 10 10. 10.1 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 7 10 ./... 5 4 0 0 0 0 1
REFERENCES REFERENCES references R RE REF REFE BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 7 10 no 0 10 1 1 0 0 1
1. Sung, 1. 1 1. 1. 1. BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 .,.,,.,,..,,.,,.,, 18 10 1 1 0 0 1
A., et a., A A. A., A., BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 10 .,.(): 6 8 1 1 0 0 1
incidence and incidence i in inc inci BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 10 . 1 8 1 1 0 0 1
Cancer J. cancer C Ca Can Canc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 10 ..,- 4 3 1 1 0 0 1
2. Lavanya, 2. 2 2. 2. 2. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 .,.,,.,,.,,.,,.() 17 9 1 1 0 0 1
molecule inhibitors molecule m mo mol mole BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 10 ... 3 8 1 1 0 0 1
Ther. 1, ther. T Th The Ther BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 10 .,- 3 1 1 1 0 0 1
(Sialyl)Lewis Antigen (sialyl)lewis ( (S (Si (Sia BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 11 ()- 3 10 0 1 0 0 0
9 Mol 9 9 9 9 9 BLOCKSTART PAGEEND NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 7 11 ()() 4 10 1 1 1 0 1
3. Sharkey, 3. 3 3. 3. 3. BLOCKSTART PAGESTART SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,..,,..(): 11 8 1 0 0 0 1
new prospects new n ne new new BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 ... 3 8 1 0 0 0 1
56, 226-243 56, 5 56 56, 56, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 ,- 2 1 1 0 0 0 1
4. Costa, 4. 4 4. 4. 4. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,..,,.,,..,,.() 16 8 1 0 0 0 1
glycosylation: a glycosylation: g gl gly glyc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 :., 3 8 1 0 0 0 1
757-766 757-766 757-766 7 75 757 757- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 - 1 0 1 0 0 0 1
5. Pinho, 5. 5 5. 5. 5. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,..,,..(): 11 8 1 0 0 0 1
and clinical and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 ...,- 5 6 1 0 0 0 1
6. Bastian, 6. 6 6. 6. 6. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,.,,.,,..,,.()-(,)- 20 9 1 0 0 0 1
fucosyltransferase in fucosyltransferase f fu fuc fuco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 ....., 6 6 1 0 0 0 1
7. Groux-Degroote, 7. 7 7. 7. 7. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .-,.,,.,,.,,.,- 15 8 1 0 0 0 1
Lepers, A. lepers, L Le Lep Lepe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 0 ,.()()()- 9 7 1 0 0 0 1
thesis in thesis t th the thes BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 .,- 3 7 1 0 0 0 1
8. Deschuyter, 8. 8 8. 8. 8. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,.,,..,,.,,.,,., 17 8 1 0 0 0 1
Petit, J. petit, P Pe Pet Peti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 ,..()- 6 8 1 0 0 0 1
colorectal cancer colorectal c co col colo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 ....,- 6 8 1 0 0 0 1
9. Venturi, 9. 9 9. 9. 9. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,.,,.,,.,,.,,., 16 8 1 0 0 0 1
Chiricolo, M., chiricolo, C Ch Chi Chir BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 ,.,.()- 7 8 1 0 0 0 1
expression on expression e ex exp expr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 .,- 3 8 1 0 0 0 1
695 695 695 6 69 695 695 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 0 no 0 0 1 0 0 0 1
10. Kellokumpu, 10. 1 10 10. 10. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,.,,.,,.()- 12 8 1 0 0 0 1
sylation and sylation s sy syl syla BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 : 1 8 1 0 0 0 1
intra-Golgi pH. intra-golgi i in int intr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 -..,- 5 4 1 0 0 0 1
11. Gill, 11. 1 11 11. 11. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,..,,.,,.,,.()- 16 9 1 0 0 0 1
glycosylation through glycosylation g gl gly glyc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 --.. 4 8 1 0 0 0 1
Biol. 189, biol. B Bi Bio Biol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 .,- 3 2 1 0 0 0 1
12. Kumamoto, 12. 1 12 12. 12. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,.,,.,,.,,.,,.,- 17 8 1 0 0 0 1
kita, M., kita, k ki kit kita BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 ,.,.()- 7 8 1 0 0 0 1
messenger RNA messenger m me mes mess BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 7 0 no 0 7 1 0 0 0 1
synthesis of synthesis s sy syn synt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 -/- 3 7 1 0 0 0 1
terminants. Cancer terminants. t te ter term BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 ..,- 4 4 1 0 0 0 1
13. Hakomori, 13. 1 13 13. 13. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,.(): 6 9 1 0 0 0 1
an old an a an an an BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 7 0 ........,- 10 7 1 0 0 0 1
14. Seales, 14. 1 14 14. 14. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,..,,..,,..,,..,,.., 21 9 1 0 0 0 1
and Bellis, and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 ,..(), 6 8 1 0 0 0 1
adenocarcinoma, may adenocarcinoma, a ad ade aden BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 ,- 2 8 1 0 0 0 1
cell motility. cell c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 ..,- 4 4 1 0 0 0 1
15. Nakamori, 15. 1 15 15. 15. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,.,,.,,.,,.,,., 16 8 1 0 0 0 1
Sasaki, Y., sasaki, S Sa Sas Sasa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 ,.,.() 6 8 1 0 0 0 1
correlates with correlates c co cor corr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 :- 2 8 1 0 0 0 1
copathological and copathological c co cop copa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 ..,- 4 7 1 0 0 0 1
3637 3637 3637 3 36 363 3637 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 0 no 0 0 1 0 0 0 1
16. Wang, 16. 1 16 16. 16. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,.-.,,.-.,,.-.,,.-.,,..,,.-.,. 31 10 1 0 0 0 1
(2002) CA19-9 (2002) ( (2 (20 (200 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 7 0 ()- 3 8 1 0 0 0 1
colorectal cancer. colorectal c co col colo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 .,- 3 6 1 0 0 0 1
17. Singh, 17. 1 17 17. 17. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,.,,.,,.,,.() 14 9 1 0 0 0 1
and role and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 ,,-- 4 7 1 0 0 0 1
colorectal cancers. colorectal c co col colo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 ....,- 6 7 1 0 0 0 1
18. Wu, 18. 1 18 18. 18. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,.,,.,,.(),-, 14 8 1 0 0 0 1
CA72-4 in ca72-4 C CA CA7 CA72 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 --..... 7 8 1 0 0 0 1
Pathol. 13, pathol. P Pa Pat Path BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 .,- 3 2 1 0 0 0 1
19. Reis, 19. 1 19 19. 19. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,..,,.,,.,,.,,.() 18 9 1 0 0 0 1
in glycosylation in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 7 0 ...., 5 8 1 0 0 0 1
322-329 322-329 322-329 3 32 322 322- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 - 1 0 1 0 0 0 1
20. Berg, 20. 2 20 20. 20. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,...,,..,,..,,.,,., 20 9 1 0 0 0 1
Danielsen, S. danielsen, D Da Dan Dani BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 ,..,.()- 8 9 1 0 0 0 1
-a resource -a - -a -a -a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 -.., 4 6 1 0 0 0 1
21. Wang, 21. 2 21 21. 21. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,.,,.,,.,,..,-, 16 8 1 0 0 0 1
G. S. g. G G. G. G. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 ...,,.()- 9 8 1 0 0 0 1
cans of cans c ca can cans BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 no 0 8 1 0 0 0 1
phenotype. Mol. phenotype. p ph phe phen BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 ..., 4 5 1 0 0 0 1
22. Wang, 22. 2 22 22. 22. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,.,,.,,.,,.,,..,,., 20 9 1 0 0 0 1
et al. et e et et et BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 .()-- 5 8 1 0 0 0 1
lines. Int. lines. l li lin line BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 ....., 6 3 1 0 0 0 1
23. Madunic, 23. 2 23 23. 23. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,.,,.,,..,,.,,.,, 18 9 1 0 0 0 1
C., et c., C C. C., C., BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 .,.() 5 9 1 0 0 0 1
O-glycome reflecting o-glycome O O- O-g O-gl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 -... 4 8 1 0 0 0 1
Sci. 78, sci. S Sc Sci Sci. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 .,- 3 1 1 0 0 0 1
24. Brockhausen, 24. 2 24 24. 24. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,.,,..,,..,,.() 16 9 1 0 0 0 1
O-GalNAc glycans. o-galnac O O- O-G O-Ga BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 -.:,, 5 8 1 0 0 0 1
Harbor Laboratory harbor H Ha Har Harb BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 0 ,, 2 5 1 0 0 0 1
25. Tsuchida, 25. 2 25 25. 25. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .,.,,.,,.,,.,,.,,., 19 9 1 0 0 0 1
et al. et e et et et BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 .()(()) 7 8 1 0 0 0 1
cell lines cell c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 5 ,,- 3 8 1 0 0 0 1
thesis of thesis t th the thes BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 5 -....,- 7 7 1 0 0 0 1
26. Senda, 26. 2 26 26. 26. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .,.,,.,,.,,.,,.,,., 19 8 1 0 0 0 1
et al. et e et et et BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 .()- 4 8 1 0 0 0 1
sible for sible s si sib sibl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 - 1 8 1 0 0 0 1
lignant kidney lignant l li lig lign BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 :. 2 8 1 0 0 0 1
Biochem. J. biochem. B Bi Bio Bioc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 5 ..,- 4 2 1 0 0 0 1
27. Matsuura, 27. 2 27 27. 27. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .,.,,.,,.,,.,,.,,.,. 20 9 1 0 0 0 1
(1998) Gene (1998) ( (1 (19 (199 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 5 ()--- 5 7 1 0 0 0 1
thesize sialyl thesize t th the thes BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 ,-, 3 8 1 0 0 0 1
breast cancer. breast b br bre brea BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 5 ....,- 6 5 1 0 0 0 1
28. Hiraiwa, 28. 2 28 28. 28. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .,.,,.,,.,,.,,.,,., 19 9 1 0 0 0 1
et al. et e et et et BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 .() 3 8 1 0 0 0 1
T-cell leukemia t-cell T T- T-c T-ce BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 5 -- 2 7 1 0 0 0 1
element. Blood element. e el ele elem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 5 .,- 3 3 1 0 0 0 1
29. Watanabe, 29. 2 29 29. 29. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .,.,-,..,,.,,.() 16 8 1 0 0 0 1
GlycoPOST realizes glycopost G Gl Gly Glyc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 5 no 0 7 1 0 0 0 1
data. Nucleic data. d da dat data BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 5 ..,- 4 4 1 0 0 0 1
30. Mouradov, 30. 3 30 30. 30. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .,.,,.,,..,,..,,.,,. 20 9 1 0 0 0 1
W., et w., W W. W., W., BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 5 .,.() 5 8 1 0 0 0 1
the main the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 5 ..,- 4 7 1 0 0 0 1
3247 3247 3247 3 32 324 3247 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 8 5 no 0 0 1 0 0 0 1
31. Ahmed, 31. 3 31 31. 31. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .,.,,..,,..,,..,,.,- 20 9 1 0 0 0 1
toen, M., toen, t to toe toen BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 ,.,.() 6 8 1 0 0 0 1
cell lines. cell c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 5 ., 2 3 1 0 0 0 1
32. Kelly, 32. 3 32 32. 32. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .,..,,.,,.,,..,,..() 20 9 1 0 0 0 1
Sequence and sequence S Se Seq Sequ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 5 no 0 7 1 0 0 0 1
group alpha(1,2)fucosyltransferase group g gr gro grou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 5 (,)(). 6 7 1 0 0 0 1
enzyme-inactivating nonsense enzyme-inactivating e en enz enzy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 - 1 7 1 0 0 0 1
non-secretor phenotype. non-secretor n no non non- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 -....,- 7 6 1 0 0 0 1
33. Boren, 33. 3 33 33. 33. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .,.,,.,,..,,.,,.() 18 8 1 0 0 0 1
Attachment of attachment A At Att Atta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 5 no 0 8 1 0 0 0 1
by blood by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 5 .,- 3 5 1 0 0 0 1
34. Kukowska-Latallo, 34. 3 34 34. 34. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .-,..,,..,,..,,..() 19 9 1 0 0 0 1
A cloned a A A A A BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 8 5 - 1 7 1 0 0 0 1
embryonic antigen embryonic e em emb embr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 (,/,)- 6 7 1 0 0 0 1
transferase. Genes transferase. t tr tra tran BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 ..,- 4 4 1 0 0 0 1
35. Aubert, 35. 3 35 35. 35. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .,.,-,.,,.,,.,,., 17 8 1 0 0 0 1
Sadoulet, M. sadoulet, S Sa Sad Sado BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 5 ,..,.() 7 8 1 0 0 0 1
cancer cells cancer c ca can canc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 5 ..., 4 8 1 0 0 0 1
558-565 558-565 558-565 5 55 558 558- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 - 1 0 1 0 0 0 1
36. Cai, 36. 3 36 36. 36. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .,..,,..,,..,,.,,.,,..() 24 9 1 0 0 0 1
Effect of effect E Ef Eff Effe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 5 , 1 8 1 0 0 0 1
migration abilities migration m mi mig migr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 5 -... 4 8 1 0 0 0 1
Biol. (Noisy-le-grand) biol. B Bi Bio Biol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 5 .(--),- 7 3 1 0 0 0 1
37. Goelz, 37. 3 37 37. 37. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .,..,,.,,.,,.,,.,,.,. 21 10 1 0 0 0 1
(1990) ELFT: (1990) ( (1 (19 (199 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 5 ():-. 5 8 1 0 0 0 1
63, 1349-1356 63, 6 63 63, 63, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 ,- 2 1 1 0 0 0 1
38. Lowe, 38. 3 38 38. 38. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .,..,-,..,,..,,..,,.., 22 9 1 0 0 0 1
Macher, B. macher, M Ma Mac Mach BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 5 ,..,.()- 8 7 1 0 0 0 1
transferase gene transferase t tr tra tran BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 - 1 7 1 0 0 0 1
epitopes but epitopes e ep epi epit BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 --...., 7 7 1 0 0 0 1
17467-17477 17467-17477 17467-17477 1 17 174 1746 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 5 - 1 1 1 0 0 0 1
39. Mondal, 39. 3 39 39. 39. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .,.,,.,,.,,..,,..,,.., 22 9 1 0 0 0 1
et al. et e et et et BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 .()(,)--/ 9 8 1 0 0 0 1
sialyl Lewis-X sialyl s si sia sial BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 -....,- 7 8 1 0 0 0 1
40. Dupuy, 40. 4 40 40. 40. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .,.,,.,,.,,.()/ 15 9 1 0 0 0 1
study of study s st stu stud BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 5 -/-:, 5 7 1 0 0 0 1
fucosylation requires fucosylation f fu fuc fuco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 - 1 7 1 0 0 0 1
domain. Glycobiology domain. d do dom doma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 5 .,- 3 3 1 0 0 0 1
41. Nguyen, 41. 4 41 41. 41. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .,..,,..,,..,,.,,., 19 8 1 0 0 0 1
Macher, B. macher, M Ma Mac Mach BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 5 ,..(),/-..- 11 8 1 0 0 0 1
cation of cation c ca cat cati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 - 1 7 1 0 0 0 1
directed mutagenesis. directed d di dir dire BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 5 ....,- 6 6 1 0 0 0 1
42. Shetterly, 42. 4 42 42. 42. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .,.,,.,,..,,.,,.., 18 8 1 0 0 0 1
Holmes, E. holmes, H Ho Hol Holm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 5 ,..()-- 7 8 1 0 0 0 1
amines by amines a am ami amin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 ,/--- 5 8 1 0 0 0 1
acids near acids a ac aci acid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 5 ...., 5 8 1 0 0 0 1
24882-24892 24882-24892 24882-24892 2 24 248 2488 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 5 - 1 1 1 0 0 0 1
(Sialyl)Lewis Antigen (sialyl)lewis ( (S (Si (Sia BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 11 ()- 3 10 0 1 0 0 0
Mol Cell mol M Mo Mol Mol BLOCKSTART PAGEEND NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 11 ()() 4 10 1 1 1 0 1
43. Koszdin, 43. 4 43 43. 43. BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,..,,..() 10 9 1 0 0 0 1
human alpha-1,3 human h hu hum huma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 -,- 3 8 1 0 0 0 1
ligand. Biochem. ligand. l li lig liga BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 .....,- 7 6 1 0 0 0 1
44. Weston, 44. 4 44 44. 44. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,..,,..,,..,,..() 18 9 1 0 0 0 1
cloning of cloning c cl clo clon BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 (,) 3 8 1 0 0 0 1
family. Multiple family. f fa fam fami BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 . 1 8 1 0 0 0 1
Lewis x, lewis L Le Lew Lewi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 9 0 ,,... 5 8 1 0 0 0 1
Chem. 267, chem. C Ch Che Chem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 .,- 3 2 1 0 0 0 1
45. Ihara, 45. 4 45 45. 45. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,.,,.,,.,,.,,.,,.,.() 22 9 1 0 0 0 1
Crystal structure crystal C Cr Cry Crys BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 9 0 ,-,.- 5 8 1 0 0 0 1
cobiology 17, cobiology c co cob cobi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 ,- 2 2 1 0 0 0 1
46. Ortiz-Soto, 46. 4 46 46. 46. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .-,..,,.,,.,,.() 16 10 1 0 0 0 1
and functional and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 no 0 8 1 0 0 0 1
the human the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 --,-(). 7 8 1 0 0 0 1
Sci. Rep. sci. S Sc Sci Sci. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 .., 3 2 1 0 0 0 1
47. Kitagawa, 47. 4 47 47. 47. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,.,,..(),- 11 8 1 0 0 0 1
sialyltransferase that sialyltransferase s si sia sial BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 no 0 8 1 0 0 0 1
groups. J. groups. g gr gro grou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 ....,- 6 4 1 0 0 0 1
48. Basu, 48. 4 48 48. 48. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,..,,.,,.,,.() 15 9 1 0 0 0 1
glycolipid:α2-3sialyltransferases, SAT-3 glycolipid:α2-3sialyltransferases, g gl gly glyc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 :-,-(-:- 8 7 1 0 0 0 1
3sialyltransferase) and 3sialyltransferase) 3 3s 3si 3sia BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 )-(-:-- 7 7 1 0 0 0 1
transferase), from transferase), t tr tra tran BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 ),(). 5 7 1 0 0 0 1
Biochemistry 35, biochemistry B Bi Bio Bioc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 ,- 2 3 1 0 0 0 1
49. Kim, 49. 4 49 49. 49. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,.-.,,.-.,,.-.,,.-.,,..,,.-.,. 31 9 1 0 0 0 1
(1996) Molecular (1996) ( (1 (19 (199 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 0 (),,- 5 8 1 0 0 0 1
sialyltransferase (hST3Gal sialyltransferase s si sia sial BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 ()....., 8 8 1 0 0 0 1
324-327 324-327 324-327 3 32 324 324- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 - 1 0 1 0 0 0 1
50. Giordanengo, 50. 5 50 50. 50. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,.,,.,,.,,.,- 14 8 1 0 0 0 1
Lepers, A., lepers, L Le Lep Lepe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 ,.,,.,.() 9 8 1 0 0 0 1
a human a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 9 0 (-),-- 6 8 1 0 0 0 1
cell line. cell c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 ....,- 6 4 1 0 0 0 1
51. Ishii, 51. 5 51 51. 51. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,.,,.,,.,,.,,.,,.,. 20 10 1 0 0 0 1
(1998) Expression (1998) ( (1 (19 (199 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 0 () 2 8 1 0 0 0 1
for ganglioside for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 ....,- 6 7 1 0 0 0 1
52. Wu, 52. 5 52 52. 52. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,..,,..,,.,,.,,.() 19 9 1 0 0 0 1
Universal phosphatase-coupled universal U Un Uni Univ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 -. 2 8 1 0 0 0 1
21, 727-733 21, 2 21 21, 21, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 ,- 2 1 1 0 0 0 1
53. Kuhn, 53. 5 53 53. 53. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,.,,.,,.,,..,,.,,.. 20 9 1 0 0 0 1
(2013) The (2013) ( (2 (20 (201 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 0 ()-,- 5 8 1 0 0 0 1
binding mode binding b bi bin bind BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 .... 4 8 1 0 0 0 1
69, 1826-1838 69, 6 69 69, 69, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 ,- 2 1 1 0 0 0 1
54. Tom, 54. 5 54 54. 54. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,..,,..,,..,,.,,..,, 21 9 1 0 0 0 1
B. D. b. B B. B. B. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 ..().. 6 8 1 0 0 0 1
description of description d de des desc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 .,- 3 5 1 0 0 0 1
55. Brockhausen, 55. 5 55 55. 55. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,.,,.,,.,,.,,.. 16 9 1 0 0 0 1
(1998) Enzymatic (1998) ( (1 (19 (199 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 0 ()- 3 8 1 0 0 0 1
cells. Glycoconj cells. c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 ..,- 4 3 1 0 0 0 1
56. Gomes, 56. 5 56 56. 56. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,.,,.,,.,,.,,.,,., 19 9 1 0 0 0 1
et al. et e et et et BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 .()() 5 7 1 0 0 0 1
biomarker of biomarker b bi bio biom BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 .,- 3 8 1 0 0 0 1
7446 7446 7446 7 74 744 7446 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 0 no 0 0 1 0 0 0 1
57. Ugorski, 57. 5 57 57. 57. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,.,,.()():- 12 9 1 0 0 0 1
carbohydrate antigen carbohydrate c ca car carb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 no 0 8 1 0 0 0 1
cancer cells. cancer c ca can canc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 ...,- 5 5 1 0 0 0 1
58. Koprowski, 58. 5 58 58. 58. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,.,,.,,.,,.,,., 16 9 1 0 0 0 1
Fuhrer, P. fuhrer, F Fu Fuh Fuhr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 ,.() 4 8 1 0 0 0 1
antibodies. Somatic antibodies. a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 ..,- 4 5 1 0 0 0 1
59. Lee, 59. 5 59 59. 59. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,.,,...,,..()-- 16 9 1 0 0 0 1
tumor marker: tumor t tu tum tumo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 :,,...., 8 8 1 0 0 0 1
468-490 468-490 468-490 4 46 468 468- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 - 1 0 1 0 0 0 1
60. Scar 60. 6 60 60. 60. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,.,,.,,.()-: 13 9 1 0 0 0 1
clinical aspects. clinical c cl cli clin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 .:,.,.: 7 8 1 0 0 0 1
From Biochemistry from F Fr Fro From BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 ,,, 3 8 1 0 0 0 1
SH: 247-260 sh: S SH SH: SH: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 :- 2 1 1 0 0 0 1
61. Klug, 61. 6 61 61. 61. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,..,,..,,..,,..,.() 20 9 1 0 0 0 1
Purification and purification P Pu Pur Puri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 - 1 8 1 0 0 0 1
glycoprotein expressing glycoprotein g gl gly glyc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 --(-). 6 8 1 0 0 0 1
Cancer Res. cancer C Ca Can Canc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 .,- 3 3 1 0 0 0 1
62. Shimono, 62. 6 62 62. 62. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,.,,.,,.,,.,,.() 17 9 1 0 0 0 1
Immunohistochemical expression immunohistochemical I Im Imm Immu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 -- 2 8 1 0 0 0 1
rectal carcinoma. rectal r re rec rect BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 ....,- 6 6 1 0 0 0 1
63. Nakayama, 63. 6 63 63. 63. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,.,,.,,.,,.,,. 15 8 1 0 0 0 1
(1995) Expression (1995) ( (1 (19 (199 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 5 () 2 8 1 0 0 0 1
with advanced with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 .,- 3 6 1 0 0 0 1
64. Yamada, 64. 6 64 64. 64. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,.,,..,,.,,.,,.,,., 20 9 1 0 0 0 1
et al. et e et et et BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 .() 3 8 1 0 0 0 1
activity with activity a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 no 0 8 1 0 0 0 1
cell line. cell c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 ...,- 5 4 1 0 0 0 1
65. Magnani, 65. 6 65 65. 65. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,..,,.,,.,,.,,., 17 8 1 0 0 0 1
Koprowski, H., koprowski, K Ko Kop Kopr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,.,.()- 7 7 1 0 0 0 1
associated with associated a as ass asso BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 - 1 8 1 0 0 0 1
lylated lacto-N-fucopentaose lylated l ly lyl lyla BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 --....,- 8 7 1 0 0 0 1
66. Baeckström, 66. 6 66 66. 66. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,.,,..,,.,,.,,.., 18 9 1 0 0 0 1
and Lindholm, and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 ,.()- 5 8 1 0 0 0 1
bound and bound b bo bou boun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 -- 2 7 1 0 0 0 1
associated sialyl-Lea associated a as ass asso BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 -.... 5 8 1 0 0 0 1
266, 21537-21547 266, 2 26 266 266, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 ,- 2 1 1 0 0 0 1
67. Sawada, 67. 6 67 67. 67. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,.,,..,,.()-- 14 8 1 0 0 0 1
adhesion efficiency adhesion a ad adh adhe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 no 0 8 1 0 0 0 1
manipulation of manipulation m ma man mani BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 - 1 7 1 0 0 0 1
expression levels. expression e ex exp expr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 ....,- 6 5 1 0 0 0 1
68. Abe, 68. 6 68 68. 68. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,.,,.-.,,.() 13 8 1 0 0 0 1
of difucosyl of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 () 2 7 1 0 0 0 1
in different in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 10 5 , 1 8 1 0 0 0 1
of colonic of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 ,..,- 5 7 1 0 0 0 1
2644 2644 2644 2 26 264 2644 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 10 5 no 0 0 1 0 0 0 1
69. Naitoh, 69. 6 69 69. 69. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,.,,.,,.,,.() 14 7 1 0 0 0 1
A clinicopathological a A A A A BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 10 5 - 1 8 1 0 0 0 1
(YB-2) in (yb-2) ( (Y (YB (YB- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 (-)..,- 7 6 1 0 0 0 1
70. Goupille, 70. 7 70 70. 70. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,.,,.,,.,,.() 14 9 1 0 0 0 1
colon carcinoma colon c co col colo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 10 5 (-) 3 8 1 0 0 0 1
gene transfection. gene g ge gen gene BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 10 5 .,- 3 4 1 0 0 0 1
71. Ito, 71. 7 71 71. 71. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,.,,.,-,.,,.,,., 17 8 1 0 0 0 1
Kasai, Y., kasai, K Ka Kas Kasa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,.,.() 6 8 1 0 0 0 1
species of species s sp spe spec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 -- 2 8 1 0 0 0 1
tissues. Int. tissues. t ti tis tiss BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 ...,- 5 4 1 0 0 0 1
72. de 72. 7 72 72. 72. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,.,,..,,..,,..,,. 18 9 1 0 0 0 1
H., and h., H H. H., H., BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 .,,..() 7 8 1 0 0 0 1
constructs of constructs c co con cons BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 ,/-. 4 7 1 0 0 0 1
Replacement of replacement R Re Rep Repl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 5 no 0 7 1 0 0 0 1
fucosyltransferase V fucosyltransferase f fu fuc fuco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 - 1 8 1 0 0 0 1
hydrolyzing activity. hydrolyzing h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 ....,- 6 5 1 0 0 0 1
73. Weston, 73. 7 73 73. 73. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,..,,..,,..,,..() 18 9 1 0 0 0 1
a novel a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 10 5 (,)- 4 7 1 0 0 0 1
parison to parison p pa par pari BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 (,/,) 5 8 1 0 0 0 1
gene. Syntenic, gene. g ge gen gene BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 .,, 3 7 1 0 0 0 1
distinct acceptor distinct d di dis dist BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 ....,- 6 8 1 0 0 0 1
74. Hu, 74. 7 74 74. 74. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,.,,.,,.,,.() 14 8 1 0 0 0 1
polymorphisms with polymorphisms p po pol poly BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 .,- 3 6 1 0 0 0 1
75. do 75. 7 75 75. 75. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,...,,...,,...() 17 9 1 0 0 0 1
FUT3 expression fut3 F FU FUT FUT3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 no 0 8 1 0 0 0 1
patients. Glycoconj patients. p pa pat pati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 ..,- 4 4 1 0 0 0 1
76. Zhan, 76. 7 76 76. 76. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,.,,.,,.() 11 8 1 0 0 0 1
proliferation, migration, proliferation, p pr pro prol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 ,,- 3 7 1 0 0 0 1
pancreatic cancer pancreatic p pa pan panc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 ...,- 5 5 1 0 0 0 1
77. Trinchera, 77. 7 77 77. 77. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,.,,.,,.,,.,,.,,., 19 10 1 0 0 0 1
et al. et e et et et BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 .()- 4 8 1 0 0 0 1
colorectal cancer colorectal c co col colo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 no 0 8 1 0 0 0 1
inhibited by inhibited i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 -.... 5 8 1 0 0 0 1
Biol. 43, biol. B Bi Bio Biol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 .,- 3 2 1 0 0 0 1
78. Blochl, 78. 7 78 78. 78. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,.,,.,,..,-,..., 17 8 1 0 0 0 1
Wuhrer, M. wuhrer, W Wu Wuh Wuhr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,.() 4 7 1 0 0 0 1
acute myeloid acute a ac acu acut BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 .., 3 5 1 0 0 0 1
79. Labarri 79. 7 79 79. 79. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,.,,..,,.,,.,,.,, 18 9 1 0 0 0 1
K., et k., K K. K., K., BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 .,.() 5 7 1 0 0 0 1
tumorigenicity of tumorigenicity t tu tum tumo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 ..,- 4 7 1 0 0 0 1
6281 6281 6281 6 62 628 6281 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 10 5 no 0 0 1 0 0 0 1
80. Tsuboi, 80. 8 80 80. 80. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,.,,.,,.,,.,,.,,.,. 20 9 1 0 0 0 1
(2007) Alpha1,2fucosylation (2007) ( (2 (20 (200 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 5 (), 3 7 1 0 0 0 1
prognosis for prognosis p pr pro prog BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 ,, 2 8 1 0 0 0 1
Lewis X lewis L Le Lew Lewi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 10 5 ... 3 8 1 0 0 0 1
Oncol. 14, oncol. O On Onc Onco BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 .,- 3 2 1 0 0 0 1
(Sialyl)Lewis Antigen (sialyl)lewis ( (S (Si (Sia BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 11 ()- 3 10 0 1 0 0 0
11 Mol 11 1 11 11 11 BLOCKSTART PAGEEND NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 11 11 ()() 4 10 1 1 1 0 1
81. Montavon 81. 8 81 81. 81. BLOCKSTART PAGESTART SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,.,,.,,.,,., 13 7 0 0 0 0 1
Hacker, N. hacker, H Ha Hac Hack BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 ,..,,.,.() 10 6 0 0 0 0 1
prognostic factor prognostic p pr pro prog BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 . 1 7 0 0 0 0 1
One 13, one O On One One BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 0 , 1 1 0 0 0 0 1
82. Orlow, 82. 8 82 82. 82. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,.,,.,,.,,.,,.,,. 18 8 0 0 0 0 1
F., et f., F F. F., F., BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 .,.() 5 7 0 0 0 0 1
histoblood group histoblood h hi his hist BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 ()... 5 7 0 0 0 0 1
75, 819-824 75, 7 75 75, 75, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 ,- 2 1 0 0 0 0 1
83. Decenzo, 83. 8 83 83. 83. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,..,,.,,..() 13 8 0 0 0 0 1
prognosis of prognosis p pr pro prog BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 .. 2 8 0 0 0 0 1
Urol. 114, urol. U Ur Uro Urol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 .,- 3 2 0 0 0 0 1
84. Mandel, 84. 8 84 84. 84. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,.,,..,,..,,..,- 17 8 0 0 0 0 1
kov, J., kov, k ko kov kov, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 ,.,,.,.()---/ 13 7 0 0 0 0 1
B-gene-defined glycosyltransferases b-gene-defined B B- B-g B-ge BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 -- 2 6 0 0 0 0 1
epithelia: correlation epithelia: e ep epi epit BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 :/-... 6 7 0 0 0 0 1
Cancer 52, cancer C Ca Can Canc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 0 ,- 2 1 0 0 0 0 1
85. Lai, 85. 8 85 85. 85. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,..,,..,,..,,..,,..,,..,.() 28 10 0 0 0 0 1
Fucosyltransferase 1 fucosyltransferase F Fu Fuc Fuco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 . 1 8 0 0 0 0 1
Death Discov. death D De Dea Deat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 0 ., 2 2 0 0 0 0 1
86. Holst, 86. 8 86 86. 86. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,.,,..,,.,,.,,. 16 8 0 0 0 0 1
(2019) N-Glycomic (2019) ( (2 (20 (201 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 0 ()- 3 7 0 0 0 0 1
mRNA expression mrna m mR mRN mRNA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 ., 2 6 0 0 0 0 1
87. Holst, 87. 8 87 87. 87. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,.,,..,,..,,..,-,.., 21 9 0 0 0 0 1
Koeleman, C. koeleman, K Ko Koe Koel BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 ,..,.()- 8 7 0 0 0 0 1
cancer cell cancer c ca can canc BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 no 0 8 0 0 0 0 1
and caudal and a an and and BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 5 ()/... 6 8 0 0 0 0 1
Proteomics 15, proteomics P Pr Pro Prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 5 ,- 2 2 0 0 0 0 1
88. Jones, 88. 8 88 88. 88. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 5 .,..,,.,,.,,..,,.,,.,. 22 9 0 0 0 0 1
(2015) The (2015) ( (2 (20 (201 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 5 ()-- 4 7 0 0 0 0 1
stem cell stem s st ste stem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 5 ........,- 10 8 0 0 0 0 1
E1558 E1558 e1558 E E1 E15 E155 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 5 no 0 0 0 0 0 0 1
89. Sizemore, 89. 8 89 89. 89. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 5 .,..,,..,,.,,.. 15 9 0 0 0 0 1
(2017) The (2017) ( (2 (20 (201 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 5 (). 3 8 0 0 0 0 1
Nat. Rev. nat. N Na Nat Nat. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 5 ..,- 4 3 0 0 0 0 1
90. Wallace, 90. 9 90 90. 90. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 5 .,..,,.,,.,-,..,,., 19 9 0 0 0 0 1
Martin, C., martin, M Ma Mar Mart BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 5 ,.,.() 6 8 0 0 0 0 1
in breast in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 11 5 ., 2 4 0 0 0 0 1
91. Biroccio, 91. 9 91 91. 91. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 5 .,.,,.,',.,',.,,.,- 19 9 0 0 0 0 1
lese, M., lese, l le les lese BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 5 ,.,.()-- 8 8 0 0 0 0 1
prognosis in prognosis p pr pro prog BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 5 :... 4 8 0 0 0 0 1
Pathol. 158, pathol. P Pa Pat Path BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 5 .,- 3 2 0 0 0 0 1
92. Stenman, 92. 9 92 92. 92. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 5 .,.,,..,,.() 12 9 0 0 0 0 1
old oncogene: old o ol old old BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 5 : 1 8 0 0 0 0 1
cancer. Cell cancer. c ca can canc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 5 .,- 3 3 0 0 0 0 1
93. Fry, 93. 9 93 93. 93. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 5 .,..,,.()-.. 12 9 0 0 0 0 1
37, 46-65 37, 3 37 37, 37, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 5 ,- 2 1 0 0 0 0 1
94. Sveen, 94. 9 94 94. 94. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 5 .,.,,.,,..,,..,,.,,., 21 10 0 0 0 0 1
et al. et e et et et BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 5 .() 3 8 0 0 0 0 1
to preclinical to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 5 - 1 8 0 0 0 0 1
pendencies. Clin pendencies. p pe pen pend BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 5 .,- 3 4 0 0 0 0 1
(Sialyl)Lewis Antigen (sialyl)lewis ( (S (Si (Sia BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 11 ()- 3 10 0 1 0 0 0
Mol Cell mol M Mo Mol Mol BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 11 ()() 4 10 1 1 1 0 1

